Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
Delia Bishara1, David Taylor1,21Pharmacy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, UK; 2Division of Pharmaceutical Sciences, King’s College, London, UKAbstract: Asenapine is a new atypical antipsychotic agent currently under development for the t...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a505025bb6854ca5b5e8c41bb5f7597a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|